Cargando…

Risk Factors of Graft-Versus-Host Disease in the Iranian Allogeneic Hematopoietic Stem Cell Transplantation: A 10-Year Experience

Background: Graft-versus-host disease (GVHD) is a serious complication associated with allogeneic hematopoietic stem cell transplantation (allo-HSCT). Thus, it is necessary to evaluate the risk factors of GVHD in allo-HSCT. Herein, we studied the effects of some risk factors on GVHD incidence in pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mehdizadeh, Mahshid, Parkhideh, Sayeh, Salari, Sina, Roshandel, Elham, Kazemi, Mohammad Hossein, Bonakchi, Hossein, Soleimani, Masoud, Hajifathali, Abbas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iran University of Medical Sciences 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840863/ https://www.ncbi.nlm.nih.gov/pubmed/35321387 http://dx.doi.org/10.47176/mjiri.35.145

Ejemplares similares

Association of HScore Parameters with Severe COVID-19: A Systematic Review and Meta-Analysis
por: Hossein Kazemi, Mohammad, et al.
Publicado: (2021)

The role of serum uric acid in the prediction of graft‐versus‐host disease in allogeneic hematopoietic stem cell transplantation
por: Ghasemi, Katayoon, et al.
Publicado: (2020)

An Intelligent Clinical Decision Support System for Predicting Acute Graft-versus-host Disease (aGvHD) following Allogeneic Hematopoietic Stem Cell Transplantation
por: Salehnasab, Cirruse, et al.
Publicado: (2021)

The effect of granulocyte colony‐stimulating factor dose and administration interval after allogeneic hematopoietic cell transplantation on early engraftment of neutrophil and platelet
por: Noorazar, Leila, et al.
Publicado: (2021)

PI3 kinase signaling pathway in hematopoietic cancers: A glance in miRNA's role
por: Roshandel, Elham, et al.
Publicado: (2021)

Adverse Effects of Busulfan Plus Cyclophosphamide versus Busulfan Plus Fludarabine as Conditioning Regimens for Allogeneic Bone Marrow Transplantation
por: Mehdizadeh, Mahshid, et al.
Publicado: (2021)

The association of conditioning regimen with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
por: Mardani, Masoud, et al.
Publicado: (2020)

The association of disease type, pre-transplant hemoglobin level and platelet count with transfusion requirement after autologous hematopoietic stem cell transplantation
por: Tabasi, Shabnam, et al.
Publicado: (2021)

Post‐hematopoietic stem cell transplantation relapse: Role of checkpoint inhibitors
por: Roshandel, Elham, et al.
Publicado: (2022)

The Association of HLA Class 1 and Class 2 Antigens with Multiple Myeloma in Iranian Patients
por: Sayad, Arezou, et al.
Publicado: (2014)

A 16 Month Survey of Cyclosporine Utilization Evaluation in Allogeneic Hematopoietic Stem Cell Transplant Recipients
por: Tavakoli Ardakani, Maria, et al.
Publicado: (2016)

Plasma levels of norepinephrine and expression levels of ß2-adrenergic receptor gene correlate with the incidence of acute graft-versus-host disease
por: Momeni-Varposhti, Zahra, et al.
Publicado: (2020)

Evaluation of Cyclosporine Pharmacokinetic, Monitoring, and Dosing Parameters for GVHD Prophylaxis in Hematopoietic Stem Cell Transplant (HSCT) Recipients
por: Tafazoli, Ali, et al.
Publicado: (2019)

The Evaluation of Melatonin Effects on Mobilization and Engraftment in Autologous Hematopoietic Stem Cell Transplant Recipients; A Randomized, Double-blind and Placebo-controlled Trial
por: Kazeminia, Neda, et al.
Publicado: (2021)

The Association of HLA-Class I and Class II with Hodgkin's Lymphoma in Iranian Patients
por: Sayad, Arezou, et al.
Publicado: (2014)

HOTAIR Long Noncoding RNA is not a Biomarker for Acute Myeloid Leukemia (AML) in Iranian Patients
por: Sayad, Arezou, et al.
Publicado: (2017)

Association between Interlukin-6 (IL-6), Interlukin-10 (IL-10) and depression in patients undergoing Hematopoietic stem cell transplantation
por: Tavakoli-Ardakani, Maria, et al.
Publicado: (2015)

Survival of Patients with Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation: An Experience in Developing Country
por: Mehdizadeh, Mahshid, et al.
Publicado: (2022)

Decidual stromal cell therapy for generalized lymphadenopathy as a special clinical manifestation of COVID‐19 infection: A case report
por: Pirsalehi, Ali, et al.
Publicado: (2022)

Oral Ciprofloxacin Prophylaxis in Patients Undergoing High DoseTherapy and Autologous Hematopoietic Stem Cell Transplantation
por: Tabarraee, Mahdi, et al.
Publicado: (2016)

Expansion of CD133(+) Umbilical Cord Blood Derived Hematopoietic Stem Cells on a Biocompatible Microwells
por: Soufizomorrod, Mina, et al.
Publicado: (2013)

Expansion of cord blood stem cells in fibronectin-coated microfluidic bioreactor
por: Moghadasi, Mohamad Hossein, et al.
Publicado: (2022)

Application of latent class analysis in diagnosis of graft-versus-host disease by serum markers after allogeneic haematopoietic stem cell transplantation
por: Amini, Maedeh, et al.
Publicado: (2020)

Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease
por: van Lier, Yannouck F., et al.
Publicado: (2023)

Virus-Specific T Cells: Promising Adoptive T Cell Therapy Against Infectious Diseases Following Hematopoietic Stem Cell Transplantation
por: Jalili, Arsalan, et al.
Publicado: (2023)

Plerixafor in the Treatment of Stem Cell Mobilization Failure; First Experience in Iran
por: Mehdizadeh, Mahshid, et al.
Publicado: (2013)

Plasma exchange followed by convalescent plasma transfusion in COVID-19 patients
por: Roshandel, Elham, et al.
Publicado: (2021)

MicroRNA-125b as a valuable predictive marker for outcome after autologous hematopoietic stem cell transplantation
por: Rafiee, Mohammad, et al.
Publicado: (2023)

The Impact of Different Cell Culture Mediums on CD8+T Cells Expansion: A Bioinformatics Study
por: Jalili, Arsalan, et al.
Publicado: (2022)

Comparison of the Effects of Plasmapheresis, Hemoperfusion, and Convalescent Plasma Therapy on Inflammatory Factors in COVID-19 Patients
por: Akhlaghi, Sedighe Sadadt, et al.
Publicado: (2022)

Immune Reconstitution and Graft-Versus-Host Reactions in Rat Models of Allogeneic Hematopoietic Cell Transplantation
por: Zinöcker, Severin, et al.
Publicado: (2012)

Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
por: Nassar, Amr, et al.
Publicado: (2014)

Metabolic Targets for Improvement of Allogeneic Hematopoietic Stem Cell Transplantation and Graft-vs.-Host Disease
por: Tijaro-Ovalle, Natalia M., et al.
Publicado: (2019)

Natural Killer Cells in Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation
por: Simonetta, Federico, et al.
Publicado: (2017)

Graft conditioning with fluticasone propionate reduces graft‐versus‐host disease upon allogeneic hematopoietic cell transplantation in mice
por: Varady, Erika S, et al.
Publicado: (2023)

Immunotherapy with adoptive cytomegalovirus‐specific T cells transfer: Summarizing latest gene engineering techniques
por: Mehdizadeh, Mahshid, et al.
Publicado: (2021)

Optimizing allogeneic grafts in hematopoietic stem cell transplantation
por: Xu, Zheng‐Li, et al.
Publicado: (2021)

Muscle Cramps and Neuropathies in Patients with Allogeneic Hematopoietic Stem Cell Transplantation and Graft-versus-Host Disease
por: Kraus, Peter D., et al.
Publicado: (2012)

Helper Innate Lymphoid Cells in Allogenic Hematopoietic Stem Cell Transplantation and Graft Versus Host Disease
por: Quatrini, Linda, et al.
Publicado: (2020)

Dermoscopy of Cutaneous Graft-Versus-Host-Disease in Patients After Allogeneic Hematopoietic Stem Cell Transplantation
por: Kaminska-Winciorek, Grażyna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l1crnbsje1r32dmqiek5a7mmpd